Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-11-21
    E.g., 2018-11-21



224 items
3:14 PM, Oct 11, 2018  |  BC Innovations | Strategy

Border security for China’s genomes

China’s policies on sharing genomic data have so far produced cumbersome but manageable hurdles for cross-border clinical trials and translational research. But the explosive growth of its genomics industry, and the backdrop of rising political...
3:59 PM, Jul 12, 2018  |  BC Innovations | Strategy

HEAL-ing pain at NIH

In a move that could change how pain is studied and treated, NIH is planning a series of projects to build a platform for translational research that is more predictive and reproducible than the current...
4:55 PM, Jun 14, 2018  |  BC Innovations | Strategy

Meta on data

NIH is grasping the nettle and turning its attention to solving the big practical questions about big data. Stopping short of a vision for how data science should drive discovery, NIH has laid out a...
11:54 AM, May 10, 2018  |  BC Innovations | Strategy

Finding phenotype

NIH wants to find direct relationships between genes and disease more efficiently than GWAS or other standard approaches allow. The institute has teamed up with Inova Health System to create a searchable pool of genomes...
3:29 PM, May 03, 2018  |  BC Innovations | Strategy

Seeking CRISP answers

The ongoing litigation in the U.S. over CRISPR-Cas9 patents could be resolved this year, but it will take longer to get a clear picture of the global CRISPR IP landscape. It is possible that companies...
3:00 PM, Mar 22, 2018  |  BC Innovations | Strategy

Janssen’s virtual discovery

In the latest example of how AI can accelerate drug discovery, Janssen has shown it can use machine learning to create virtual drug screens that outperform conventional assays. The most promising application may be in...
5:09 PM, Feb 15, 2018  |  BC Innovations | Strategy

Pfizer’s chemistry machine

With the goal of creating a step-change in the optimization of small molecules in discovery research, Pfizer Inc. has built a continuous flow machine that rapidly tests thousands of chemical reactions using submilligram quantities of...
11:10 AM, Feb 06, 2018  |  BC Innovations | Strategy


In an era of heightened concerns about the politicization of science, it would be logical to expect peer-reviewed journals, the beating heart of the scientific enterprise, to recognize the need to shield science and scientists...
3:13 PM, Jan 25, 2018  |  BC Innovations | Strategy

Takeda rides Denali’s ATV

In its deal with Denali, Takeda has not only boosted its CNS pipeline, but also gained access to a delivery technology that could open the door to a host of CNS targets only druggable with...
7:19 PM, Jan 18, 2018  |  BC Innovations | Strategy

After amyloid

As the Alzheimer’s field is slowly taking on the search for new targets outside of the β amyloid and tau hypotheses, researchers are ramping up exploration of new pathways and looking to the disease’s genetics...